News
Filter
-
LifeArc and Kings College London team up to accelerate MND treatment development by driving systematic target validation
-
Britain’s largest health research programme, Our Future Health, forms new £10m partnership with LifeArc
-
LifeArc welcomes the UK government’s national action plan for antimicrobial resistance (AMR)
-
LifeArc Translational Science Summit: Highlights and key takeaways
-
LifeArc launches £40m research centres that will unlock new tests, treatments and cures for people living with rare diseases
-
Dr Sam Barrell CBE appointed as CEO of LifeArc
-
First-of-a-kind plan announced to get more children access to cutting-edge, proven gene therapy treatments for rare diseases
-
New £6.2m partnership will help to eliminate a deadly disease affecting children and vulnerable people in Kenya
-
LifeArc supports 8 new fellows through Crick Africa Network (CAN) partnership
-
LifeArc signs statement calling for the UK to lead the G7 on R&D investment
-
LifeArc funds pivotal clinical trial to treat an ultra-rare genetic disease with possible link to leader of the mutiny on the Bounty in 1789
-
ReAct Africa and LifeArc announce launch of ASPIRE initiative to combat antimicrobial resistance in Zambia and Kenya
